Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
RNA-seq03:21

RNA-seq

10.1K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance.

Genome medicine·2026
Same author

A pan-cancer single-cell analysis of intratumoral copy number diversity and evolution.

Cancer discovery·2026
Same author

H3K27M-driven hypertranscription leads to a new targetable dependency in diffuse midline gliomas.

bioRxiv : the preprint server for biology·2026
Same author

Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression.

Cancer cell·2026
Same author

Radiation Oncology-Biology Integration Network: Bridging the Gap between Biological Research and Clinical Practice.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies.

Cancer discovery·2026
Same journal

Photocatalytic low-temperature defluorination of PTFE.

Nature protocols·2026
Same journal

Multimodal imaging and quantification of lanthanide chelate-labeled micro- and nanoplastics in plants.

Nature protocols·2026
Same journal

Facilitating structure-based drug discovery with an artificial intelligence-driven virtual screening platform.

Nature protocols·2026
Same journal

Yeast nuclei-mediated precise delivery of synthetic megabase-scale human DNA into mammalian embryos.

Nature protocols·2026
Same journal

Direct inoculation of bioreactor-controlled stirred suspension culture with cryopreserved human pluripotent stem cells.

Nature protocols·2026
Same journal

Whole-organ spatial transcriptional analysis at cellular resolution using TRISCO.

Nature protocols·2026
See all related articles

Related Experiment Video

Updated: Jul 24, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA.

Lin Yang1, Jin Wang1,2, Jennifer Altreuter1

  • 1Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.

Nature Protocols
|June 30, 2023
PubMed
Summary
This summary is machine-generated.

This tutorial simplifies tumor immune characterization using RNA-sequencing (RNA-seq) data. It introduces computational tools and the RIMA pipeline to make complex analyses accessible for cancer research.

More Related Videos

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

3.0K
Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance
04:58

Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance

Published on: December 13, 2024

2.6K

Related Experiment Videos

Last Updated: Jul 24, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

3.0K
Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance
04:58

Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance

Published on: December 13, 2024

2.6K

Area of Science:

  • Oncology
  • Bioinformatics
  • Immunology

Background:

  • RNA-sequencing (RNA-seq) is a cost-effective method for tumor molecular profiling and immune characterization.
  • Numerous computational tools exist for analyzing gene expression data in cancer immunology.
  • Analyzing large-scale RNA-seq data demands significant bioinformatics expertise and computational resources.

Purpose of the Study:

  • To provide an overview of computational analysis for tumor immune characterization using bulk RNA-seq data.
  • To introduce essential computational tools relevant to cancer immunology and immunotherapy.
  • To present the RNA-seq IMmune Analysis (RIMA) pipeline for streamlined analysis and a user-friendly guide.

Main Methods:

  • Overview of computational analysis strategies for bulk RNA-seq in tumor immunology.
  • Introduction to diverse computational tools for evaluating expression signatures, immune infiltration, immune repertoire, immunotherapy response prediction, neoantigen detection, and microbiome quantification.
  • Description of the RIMA pipeline, integrating multiple tools for efficient RNA-seq analysis.

Main Results:

  • The RIMA pipeline integrates various computational tools for comprehensive tumor immune characterization.
  • A user-friendly GitBook guide with demos is available for analyzing RNA-seq data at sample and cohort levels.
  • The tutorial aims to lower the barrier for researchers in utilizing RNA-seq for cancer immunology studies.

Conclusions:

  • Computational analysis of bulk RNA-seq data is crucial for understanding tumor immunity.
  • The RIMA pipeline and accompanying guide facilitate accessible and efficient immune characterization from RNA-seq data.
  • This resource empowers researchers to leverage RNA-seq for advancing cancer immunology and immunotherapy research.